Search

Dan W Urry

from Vestavia, AL
Age ~89
Get Report
Also known as:
Dan Dr Urry, Dan Wesley Urry, Dan W Wurry
Phone and address:
2423 Vestavia Dr, Birmingham, AL 35216
(205) 979-4293
Related to:
Michelle Marie Bushey, 64Wes D Urry, 63Kelley Urry, 43Doris L LakeKathleen L Urry, 83Kathleen A UrryDavid W Urry, 59
Connected to:
Amanda N Urry, 36Dane R Urry, 43Heather E Urry, 53Jay A Urry, 62Kristi A Urry, 65Scott W Urry, 54Steven G Urry, 58Hemanth T Urs, 40Sharath S Urs, 39Elena C Ursache, 50

Dan Urry Phones & Addresses

  • 2423 Vestavia Dr, Birmingham, AL 35216 (205) 979-4293
  • Vestavia, AL
  • 316 2Nd St, Stillwater, MN 55082 (651) 351-2810
  • Saint Paul, MN
  • Jefferson, AL
  • Wilmington, DE

Education

Degree: Graduate or professional degree

Emails

u***[email protected]

Resumes

Resumes

Dan Urry Photo 1

Chairman

View page
Location:
Birmingham, AL
Industry:
Research
Work:
Bioelastics
Chairman
Dan Urry Photo 2

Owner

View page
Location:
Birmingham, AL
Industry:
Research
Work:
Bioelastics
Owner

Business Records

Name / Title
Company / Classification
Phones & Addresses
Dan W Urry
incorporator
The Biotechnology Association of Alabama
PROMOTE THE COMMON BUSINESS INTEREST OF BIOTECHNOLOGY
Birmingham, AL

Publications

Us Patents

Injectable Implants For Tissue Augmentation And Restoration

View page
US Patent:
6533819, Mar 18, 2003
Filed:
Apr 23, 2001
Appl. No.:
09/841334
Inventors:
Dan W. Urry - Birmingham AL
Timothy M. Parker - Odenville AL
Paul A. Glazer - Brookline MA
Assignee:
Bioelastics Research, Ltd. - Birmingham AL
International Classification:
A61F 244
US Classification:
623 1716
Abstract:
A method for tissue augmentation in a mammal is provided having injecting a polymer at a tissue site in need of augmentation and having a tissue temperature, the polymer having repeating peptide monomeric units selected from the group consisting of nonapeptide, pentapeptide and tetrapeptide monomeric units, wherein the monomeric units form a series of -turns separated by dynamic bridging segments suspended between the -turns, wherein the polymer has an inverse temperature transition T less than the tissue temperature, and wherein the polymer is injected as a water solution at coacervate concentration in the substantial absence of additional water. A kit containing the injectable bioelastic polymer and a syringe is also provided.

Injectable Implants For Tissue Augmentation And Restoration

View page
US Patent:
6699294, Mar 2, 2004
Filed:
Apr 18, 2001
Appl. No.:
09/837969
Inventors:
Dan W. Urry - Birmingham AL
Assignee:
Bioelastics Research, Ltd. - Birmingham AL
International Classification:
A61F 202
US Classification:
623 2372, 623 2358
Abstract:
A method for tissue augmentation in a mammal is provided comprising injecting a polymer at a tissue site in need of augmentation and having a tissue temperature, the polymer comprising repeating peptide monomeric units selected from the group consisting of nonapeptide, pentapeptide and tetrapeptide monomeric units, wherein the monomeric units form a series of -turns separated by dynamic bridging segments suspended between the -turns, wherein the polymer has an inverse temperature transition T less than the tissue temperature, and wherein the polymer is injected as a water solution at coacervate concentration in the substantial absence of additional water. A kit containing the injectable bioelastic polymer and a syringe is also provided.

Compositions And Methods For Optimizing Drug Hydrophobicity And Drug Delivery To Cells

View page
US Patent:
8626452, Jan 7, 2014
Filed:
Jun 9, 2010
Appl. No.:
12/797465
Inventors:
Dan W. Urry - Vestavia Hills AL, US
Kelley D. Urry - Vestavia Hills AL, US
International Classification:
G06F 19/00
G01N 31/00
C12Q 1/02
US Classification:
702 30, 702 22, 702 27, 435 29
Abstract:
Methods to determine drug hydrophobicity and to quantify changes in drug hydrophobicity that optimize drug function by means of differential scanning calorimetry of an endothermic phase transition of a base protein-based polymer, specifically of an elastic-contractile model protein, to which is attached the drug to be evaluated for its hydrophobicity in terms of the change in Gibbs free energy for hydrophobic association, ΔGhave been developed. Also described herein is the preparation of nanoparticles comprised of protein-based polymers, specifically of elastic-contractile model proteins, designed for the binding and desired release rate of a specific drug or class of drugs. Further described herein is a means of targeting the drug-laden nanoparticle to a cell by means of decorating the nanoparticle surface with a molecular entity that selectively binds to the diseased cell or disease causing organism, e. g. , by decorating the drug-laden nanoparticle surface with synthetic antigen-binding fragment to an up-regulated receptor characteristic of the diseased cell.

Bioelastomer Nanomachines And Biosensors

View page
US Patent:
20020068304, Jun 6, 2002
Filed:
Jun 21, 2001
Appl. No.:
09/888260
Inventors:
Dan Urry - Birmingham AL, US
International Classification:
G01N033/53
F02B001/00
US Classification:
435/007100, 060/721000
Abstract:
Bioelastomers, having repeating peptide monomeric units selected from the group consisting of bioelastic nonapeptides, pentapeptides and tetrapeptides, are used to produce nanomachines and biosensors.

Injectable Implants For Tissue Augmentation And Restoration

View page
US Patent:
20020116069, Aug 22, 2002
Filed:
Apr 23, 2001
Appl. No.:
09/841321
Inventors:
Dan Urry - Birmingham AL, US
International Classification:
A61F002/02
A61F002/28
US Classification:
623/023720, 623/023760, 623/023580
Abstract:
A method for tissue augmentation in a mammal is provided comprising injecting a polymer at a tissue site in need of augmentation and having a tissue temperature, the polymer comprising repeating peptide monomeric units selected from the group consisting of nonapeptide, pentapeptide and tetrapeptide monomeric units, wherein the monomeric units form a series of -turns separated by dynamic bridging segments suspended between the -turns, wherein the polymer has an inverse temperature transition Tless than the tissue temperature, and wherein the polymer is injected as a water solution at coacervate concentration in the substantial absence of additional water. A kit containing the injectable bioelastic polymer and a syringe is also provided.

Acoustic Absorption Polymers And Their Methods Of Use

View page
US Patent:
20030087802, May 8, 2003
Filed:
Dec 20, 2000
Appl. No.:
09/746371
Inventors:
Dan Urry - Birmingham AL, US
International Classification:
A61K038/04
C07K017/00
C07K016/00
C07K014/00
C07K007/00
C07K005/00
C07K004/00
C07K002/00
A61K038/00
A01N037/18
US Classification:
514/002000, 530/300000, 514/017000, 514/018000, 530/330000
Abstract:
A method for reducing the acoustical noise, sonar cross-section or radar cross-section of an object, in particular low frequency sonar noise, is provided comprising contacting the object with a polymer that has been optionally modified to include a charged (anionic or cationic) site. In a preferred embodiment, the polymer is a bioelastomer that has been modified to include an anionic site.

Photoresponsive Polymers

View page
US Patent:
20030166840, Sep 4, 2003
Filed:
Jan 12, 2001
Appl. No.:
09/759947
Inventors:
Dan Urry - Birmingham AL, US
David Tirrell - Sunderland MA, US
Catherine Heimbach - Birmingham AL, US
International Classification:
C07K016/00
US Classification:
530/350000, 430/269000
Abstract:
A composition that expands or contracts upon a change in exposure to light energy is provided that comprises a protein or protein-based polymeric material having an inverse temperature transition in the range of liquid water, wherein at least a fraction of the monomers in the polymer contain an light energy-responsive group that undergoes a change in hydrophobicity or polarity upon a change in exposure to light energy and is present in an amount sufficient to provide a shift in the inverse temperature transition of the polymer upon the change in exposure to light energy. Compositions of the invention, including those further containing a side-chain chemical couple, can be used in a variety of different applications to produce mechanical work, cause turbidity changes, cause chemical changes in an enclosed environment, or transduce other free energies by varying the exposure to light energy on the composition. The degree and efficiency of mechanical or chemical change can be controlled by, inter alia, selection of the type, amount, position, and mole fraction of the light energy-responsive side chain group and hydrophobic residues in the polymer.

Elastomeric Polypeptide Matrices For Preventing Adhesion Of Biological Materials

View page
US Patent:
55190049, May 21, 1996
Filed:
Jun 7, 1995
Appl. No.:
8/485495
Inventors:
Dan W. Urry - Birmingham AL
Assignee:
The UAB Research Foundation - Birmingham AL
Bioelastics Research Ltd. - Birmingham AL
International Classification:
A61K 3700
US Classification:
514 17
Abstract:
The invention provides a bioelastomer comprising tetrapeptide and/or pentapeptide monomeric units of the formula: R. sub. 1 PGR. sub. 2 G. sub. n wherein R. sub. 1 is a peptide-producing residue of alanine or glycine; P is a peptide-producing residue of proline; G is a peptide-producing residue of glycine; R. sub. 2 is a peptide-producing residue of glycine or alanine; and n is 0 or 1. In a further aspect of the invention, a method is provided for preventing adhesion of biological materials, such as protein, cells, and tissues, by forming a protective layer between a first surface and a second surface using the bioelastomer.
Control profile
Dan W Urry from Vestavia, AL, age ~89 Get Report